JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 84 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $29 | +70.6% | 15,468 | 0.0% | 0.00% | – |
| Q4 2022 | $17 | -100.0% | 15,468 | 0.0% | 0.00% | – |
| Q3 2022 | $36,000 | -21.7% | 15,468 | +0.9% | 0.00% | – |
| Q2 2022 | $46,000 | -55.8% | 15,334 | -0.2% | 0.00% | – |
| Q1 2022 | $104,000 | -70.1% | 15,372 | -63.1% | 0.00% | – |
| Q4 2021 | $348,000 | +11.2% | 41,706 | -1.0% | 0.00% | – |
| Q3 2021 | $313,000 | +9.8% | 42,119 | +0.5% | 0.00% | – |
| Q2 2021 | $285,000 | -43.3% | 41,921 | -14.3% | 0.00% | -100.0% |
| Q1 2021 | $503,000 | +46.6% | 48,934 | 0.0% | 0.00% | – |
| Q4 2020 | $343,000 | -15.3% | 48,934 | -1.4% | 0.00% | – |
| Q3 2020 | $405,000 | +18.4% | 49,634 | 0.0% | 0.00% | – |
| Q2 2020 | $342,000 | +109.8% | 49,634 | +44.5% | 0.00% | – |
| Q1 2020 | $163,000 | -15.5% | 34,356 | +55.2% | 0.00% | – |
| Q4 2019 | $193,000 | +153.9% | 22,134 | -2.6% | 0.00% | – |
| Q3 2019 | $76,000 | -29.0% | 22,734 | +5.3% | 0.00% | – |
| Q2 2019 | $107,000 | -21.9% | 21,584 | -2.3% | 0.00% | – |
| Q1 2019 | $137,000 | +80.3% | 22,084 | -1.8% | 0.00% | – |
| Q4 2018 | $76,000 | -48.6% | 22,484 | -1.3% | 0.00% | – |
| Q3 2018 | $148,000 | -15.4% | 22,784 | 0.0% | 0.00% | – |
| Q2 2018 | $175,000 | -65.9% | 22,784 | -0.7% | 0.00% | -100.0% |
| Q1 2018 | $513,000 | +75.7% | 22,934 | 0.0% | 0.00% | – |
| Q4 2017 | $292,000 | +239.5% | 22,934 | +317.0% | 0.00% | – |
| Q3 2017 | $86,000 | +11.7% | 5,500 | 0.0% | 0.00% | – |
| Q2 2017 | $77,000 | – | 5,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $22,527,000 | 93.16% |
| TRV GP III, LLC | 1,148,780 | $9,592,000 | 2.40% |
| Deep Track Capital, LP | 4,000,000 | $33,400,000 | 2.36% |
| Ally Bridge Group (NY) LLC | 575,000 | $4,801,000 | 1.68% |
| Logos Global Management LP | 1,350,000 | $11,273,000 | 1.16% |
| PFM Health Sciences, LP | 3,972,868 | $33,173,000 | 1.13% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 245,829 | $2,053,000 | 0.83% |
| Yorktown Management & Research Co Inc | 137,300 | $1,146,000 | 0.77% |
| Sofinnova Investments, Inc. | 1,582,777 | $13,216,000 | 0.77% |
| ACUTA CAPITAL PARTNERS, LLC | 127,500 | $1,065,000 | 0.45% |